Efficacy of vedolizumab (VDZ) by disease localisation in Crohn's disease

被引：0
|
作者：
Allez, M. [1 ]
Braegger, F. [2 ]
Kempf, C. [2 ]
Michetti, P. [3 ,4 ]
机构：
[1] Univ Paris 07, Hop St Louis, AP HP, INSERM,UMRS 1160,Gastroenterol & Hepatol, Paris, France
[2] Takeda Pharmaceut Int AG, Zurich, Switzerland
[3] CHU Vaudois, Crohns & Colitis Ctr, Gastroenterol Source Beaulieu, Lausanne, Switzerland
[4] CHU Vaudois, Crohns & Colitis Ctr, Div Gastroenterol, Lausanne, Switzerland
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P727
引用
收藏
页码：S479 / S479
页数：1
相关论文
共 50 条
  • [1] Efficacy of Vedolizumab (VDZ) by Disease Localisation in Crohn's Disease (CD)
    Allez, Matthieu
    Braegger, Fiona
    Kempf, Christian
    Michetti, Pierre
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 22S - 22S
  • [2] Efficacy of vedolizumab (VDZ) by disease extension in ulcerative colitis
    Michetti, P.
    Braegger, F.
    Kempf, C.
    Allez, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S402 - S403
  • [3] Efficacy of Vedolizumab (VDZ) by Disease Extension in Ulcerative Colitis (UC)
    Michetti, Pierre
    Braegger, Fiona
    Kempf, Christian
    Allez, Matthieu
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 22S - 22S
  • [4] Vedolizumab for Crohn's disease
    Mosli, Mahmoud H.
    Feagan, Brian G.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (03) : 455 - 463
  • [5] Efficacy and safety of retreatment with vedolizumab in patients with Crohn's disease
    Sands, B. E.
    Shafran, I.
    Farraye, F. A.
    Cheifetz, A. S.
    Abhyankar, B.
    Sankoh, S.
    Smyth, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S377 - S378
  • [6] Long-term Efficacy of Vedolizumab for Crohn's Disease
    Vermeire, Severine
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert R.
    Kaser, Arthur
    Panaccione, Remo
    Rubin, David T.
    Shafran, Ira
    McAuliffe, Megan
    Kaviya, Arpeat
    Sankoh, Serap
    Mody, Reema
    Abhyankar, Brihad
    Smyth, Michael
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (04): : 412 - 424
  • [7] Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease
    Huff-Hardy, Kayci
    Bedair, Mai
    Vazquez, Rebecca
    Burstein, Ezra
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : E49 - E49
  • [8] Efficacy of Vedolizumab Therapy in Patients With Perianal Crohn's Disease
    Manski, Scott
    Edirisuriya, Chelsea
    Fabrizio, Joseph
    Dioguardi, Vincent
    Gandhi, Hema K.
    Shivashankar, Raina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S847 - S848
  • [9] Efficacy and Safety of Retreatment With Vedolizumab in Patients With Crohn's Disease
    Sands, Bruce E.
    Shafran, Ira
    Farraye, Francis A.
    Cheifetz, Adam S.
    Abhyankar, Brihad
    Sankoh, Serap
    Smyth, Michael D.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S278 - S278
  • [10] EFFICACY AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB FOR CROHN'S DISEASE OF THE POUCH
    Park, Sunhee
    Keyashian, Kian
    Ho, Andrew
    Limsui, David
    Frost, Spencer
    Vazquez-Reyes, Raul
    Ebriani, Joseph
    Yang, Eleanor
    Parekh, Nimisha K.
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S146 - S146
12345